Skip to main content

Advertisement

Table 1 :

From: Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy

  No of diagnoses Incidence per 1000 PY Crude RR 95%CI Adjusted RR Model 1* 95%CI Adjusted Model 2** 95%CI
no cART and year<1996 43 0.58 1.35 [0.84;2.18] 1.14 [0.7;1.85] 0.68 [0.4;1.17]
no cART and year>=1996 28 0.79 1 1 1
[0;1] 6 2.01 3.48 [1.48;8.17] 3.09 [1.31;7.28] 1.75 [0.73;4.19]
[1;2] 2 0.68 1.19 [0.29;4.89] 1.05 [0.25;4.33] 0.30 [0.04;2.23]
[2;3] 7 2.35 4.11 [1.85;9.13] 3.62 [1.62;8.08] 2.17 [0.96;4.92]
[3;6] 8 0.94 1.63 [0.76;3.46] 1.43 [0.67;3.05] 0.90 [0.41;1.94]
≥6 93 0.58 1.00 [0.69;1.43] 0.83 [0.57;1.2] 0.75 [0.51;1.10]
  1. *adjusted for age, sex and exposure group, migration for sub-Saharan Africa, AIDS stage. **adjusted for variables in model 1 and CD4 cell count.